Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Kotapati
Q-TWiST Analysis Comparing Ipilimumab/Dacarbazine vs Placebo/Dacarbazine for Patients With Stage III/IV Melanoma
British Journal of Cancer
Cancer Research
Oncology
Cost-Effectiveness of Nivolumab in Combination With Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Health Care Resource Utilization Among Advanced Melanoma Patients in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Nivolumab (NIVO) Combined With Ipilimumab (IPI) Compared With Nivo and Ipi Monotherapies in the First-Line Treatment of Advanced Melanoma in the United States: Analysis Using 28-Month Overall Survival (OS) Data From Checkmate 067
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Preference-Based Utilities for Adjuvant Melanoma in the United Kingdom and Australia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
